NDC 63323-461-01 - SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE)
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-461
- Requested NDC
- 63323-461-01
- Package NDCs from labels
- 63323-461-01, 63323-461-57
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| SENSORCAINE MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-461-01 | SENSORCAINE | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 7 | |
| 63323-461-57 | SENSORCAINE | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-461 | SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20230712_bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-461-01 | ML - Milliliter | 63323-461 | 57ba37a9-3a24-42da-a55f-443914af5259 | 1 | 2021-06-02 |
| 63323-461-57 | ML - Milliliter | 63323-461 | 832b75a3-bb7e-4cd3-a1a3-1d99f175d18e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold Sore Formula | DULCAMARA, GLYCYRRHIZA GLABRA, RANUNCULUS BULBOSUS, RHUS TOX, NATRUM MURIATICUM, FAGOPYRUM ESCULENTUM, NATRUM HYPOCHLOROUS, ACONITUM NAPELLUS, CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I AND II NOSODE, SEPIA, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, ADENOVIREN NOSODE | Nutritional Specialties, Inc. | ad6a08ec-5eba-405b-8a07-79ac86ab3e7a | 2026-03-31 | Warnings | 451W47IQ8X |
| ANX HP | ARSENICUM ALBUM, CALCAREA CARBONICA, IGNATIA AMARA, KALI CARBONICUM, LACHESIS MUTUS, NATRUM MURIATICUM | BioActive Nutritional, Inc. | 96035891-aea3-4138-bb26-801ad819f639 | 2026-03-30 | Warnings | 451W47IQ8X |
| Spleen Liquescence | QUERCUS ROBUR, CEANOTHUS AMERICANUS, SPLEEN (BOVINE), NATRUM MURIATICUM, HELIANTHUS ANNUUS | Nutritional Specialties, Inc. | d800456d-60f0-413d-b310-91b8b881f6b9 | 2026-03-30 | Warnings | 451W47IQ8X |
| Depressoforce | PICRICUM ACIDUM, ARSENICUM ALBUM, AURUM METALLICUM, IGNATIA AMARA, NATRUM MURIATICUM, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SEPIA | BioActive Nutritional, Inc. | e6b98979-a38c-4f13-af03-f5ffa962b4fa | 2026-03-27 | Warnings | 451W47IQ8X |
| Adrenapar | ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS SUIS, ARSENICUM IODATUM, CALCAREA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM | Energique, Inc. | 077a9171-283d-47b6-bddc-34c739f6d69d | 2026-03-27 | Warnings | 451W47IQ8X |
| Articaine Hydrochloride and Epinephrine | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE | Novocol Pharmaceutical of Canada, Inc. | 636cbf11-819c-48f8-915d-ac5fb38bd352 | 2026-03-26 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Novocol Pharmaceutical of Canada, Inc. | 2005680a-8a23-4403-a618-e4ee74fa1121 | 2026-03-26 | Warnings, Adverse reactions | 30Q7KI53AK |
| Buffer pH | CHAMOMILLA, GRAPHITES, KALI CARBONICUM, KALI OXALICUM, KALI PHOSPHORICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, NUX VOMICA, RHEUM (PALMATUM), ROBINIA PSEUDOACACIA | NaturalCare | 2161a2e2-613d-4dac-a5f6-796d40e849d9 | 2026-03-25 | Warnings | 451W47IQ8X |
| Reflux Away | ABIES NIGRA, ANTIMONIUM CRUDUM, ARGENTUM NITRICUM, CARBO VEGETABILIS, CHELIDONIUM MAJUS, COLOCYNTHIS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA | NaturalCare | 8a00a72f-60df-4477-b7b8-abb6355e34da | 2026-03-24 | Warnings | 451W47IQ8X |
| Worafy Gentle Eye Wash | SODIUM CHLORIDE | Shenzhen Shandian Jingling Technology Co., Ltd. | 4da864dc-e10c-1db9-e063-6394a90a0984 | 2026-03-22 | Warnings | 451W47IQ8X |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Sportpharm LLC | 74bad838-2800-4d36-a3ee-cc1d739d24c2 | 2026-03-21 | Warnings, Adverse reactions | 30Q7KI53AK |
| SODIUM CHLORIDE HYPERTONICITY | SODIUM CHLORIDE | YYBA CORP | 439653b9-99b8-4799-8d67-4a2ada9c6783 | 2026-03-20 | Warnings | 451W47IQ8X |
| Altachlore Sodium Chloride Hypertonicity Ophthalmic 5 Percent | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | e13fd053-9420-490c-a43e-e14b0930cb4e | 2026-03-18 | Warnings | 451W47IQ8X |
| Universaltox | ALFALFA, AVENA SATIVA, FUCUS VESICULOSUS, HORDEUM VULGARE, NASTURTIUM AQUATICUM, RAPHANUS SATIVUS, TRITICUM AESTIVUM, IODIUM, UBIDECARENONUM, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, MANGANESE GLUCONATE, ORYZA SATIVA, THYROIDINUM (SUIS), CALCAREA CARBONICA, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), RHUS TOX, CORTISONE ACETICUM | BioActive Nutritional, Inc. | ad454e8a-4f78-4aac-90d9-a3f26a6fbe42 | 2026-03-17 | Warnings | 451W47IQ8X |
| epinephrine | EPINEPHRINE | Baxter Healthcare Corporation | 60efd409-3555-4182-a68d-1cd7bc0d1bfc | 2026-03-16 | Warnings, Adverse reactions | 30Q7KI53AK |
| BM BIO27 | CALC PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d229815-05f4-27c5-e063-6394a90ac865 | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO1 | CALC PHOS, FERR PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d265d99-fdbb-5efb-e063-6394a90a89ac | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO16 | CALC PHOS, FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d26b4a9-ee27-6915-e063-6294a90a5d4d | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO12 | FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d2747ad-958e-63a1-e063-6294a90aea66 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b812c9-fb0a-5ee0-e063-6294a90a03e1 | 2026-03-16 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.